MyoPro® is a unique, powered upper limb orthosis designed to restore function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. It is the only device that, sensing a patient’s own EMG signals through non-invasive sensors on the arm, can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care.
MyoPro is developed by Myomo of Cambridge, Massachusetts, and is based on technology patented originally at MIT.
Dr. Ross Zafonte is one of the world’s foremost authorities on neuromuscular rehabilitation. He is Head of the Department of Physical Medicine and Rehabilitation at Harvard Medical School, Chief of Physical Medicine and Rehabilitation at Massachusetts General Hospital as well as Senior Vice President, Medical Affairs Research and Education at Spaulding Rehabilitation Network. Dr Zafonte commented, "This innovative device, the MyoPro, is extremely important. This could enable people to change how they live their lives, at home or in a workplace. This is an exciting opportunity."
As a Myomo Center of Excellence, the Clinical Team at Handspring has invested significant time and resources to become experts in the correct utilization and custom design of this exciting new technology. "Our entire corporate philosophy is built around finding the best ways to bring the latest O&P technology to patients throughout the country," states Laura Katzenberger, Director of Clinical Services of Handspring. "Having worked with a variety of manufacturers to help them bring new products to market, our Clinical Team understands what a successful new technology can do to improve patients’ lives. We all firmly believe that the highly successful patient outcomes that we have seen from the MyoPro are just the kind of results that we strive for with all of our patients."